Technology | Magnetic Resonance Imaging (MRI) | September 07, 2016

GE Gains FDA Clearance for Multi-Contrast MRI in a Single Acquisition

510(k) cleared MAGiC imaging technique delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging

Magic, sigma Pioneer, GE, multiple contrasts in one MRI scan

An example of a Magic MRI scan that created six different contrasts from a single contrast scan. 

September 7, 2016 – The U.S. Food and Drug Administration (FDA) granted market clearance for GE Healthcare’s MAGiC (MAGnetic resonance image Compilation) software, the industry’s first multi-contrast magnetic resonance imaging (MRI) technique that delivers eight contrasts in a single acquisition in fraction of the time of conventional imaging.

MAGiC is the result of a collaboration with SyntheticMR AB and gives clinicians more data than conventional scanning. This technique gives users the flexibility to manipulate MR images retrospectively leading to significant timesaving, fewer rescans and therefore cost savings, which combined, can assist the clinician in making a more decisive diagnosis.

MAGiC is an acquisition technique that allows the ability to modify image contrast after scanning has been completed, which is not possible with conventional imaging. GE said MAGiC delivers more potential for the clinician to utilize changes in the image contrast to enhance their diagnosis. With conventional imaging, a radiologist may need to order a rescan if the proper contrast was not acquired, requiring the patient to return and the technologist to conduct another scan. With MAGiC, the radiologist can view multiple different contrasts acquired from a single scan.

"MAGIC simultaneously provides a new level of protocol efficiency and tissue characterization,” said Howard Rowley, M.D., professor of radiology, neurology and neurosurgery at the University of Wisconsin – Madison, and president of the American Society of Neuroradiology. “The flexibility to post-process a wide variety of key image families with different tissue contrasts from a single acquisition is groundbreaking. This will be a major advance for fast brain protocols and patient comfort due to the reduced scan time."

GE Healthcare has conducted and submitted to the U.S. FDA a blinded 1.5T and 3.0T, multi-center, multi-reader clinical study comparing MAGiC to conventional scanning. This study involved both MAGiC and conventional images collected from six sites and 109 patients that were evaluated by seven readers. The study verified that the image quality of MAGiC was comparable to conventional images at a fraction of the scan time, which may improve patient throughput and comfort.

For the first, clinicians will have the ability to generate multiple image contrasts in a single MR scan – including T1, T2, STIR, T1 FLAIR, T2 FLAIR, Dual IR, Phase Sensitive IR, and Proton Density weighted images of the brain in a single acquisition. To change the contrast, users simply move the cursor on the interface to change the parameters such as TR, TE and TI. MAGiC enables one scan that can do the work of many and can be processed in many unique and independent ways.

Additionally, MAGiC can generate parametric maps enabling further tissue analysis, which is key in the emerging approach of precision medicine. The measurement of tissue values like T1, T2 and PD gives clinicians more information and therefore better insights into the disease of that specific patient, leading to a more confident diagnosis.

“MAGiC is a terrific clinical innovation,” said Eric Stahre, president and CEO, GE Healthcare MR. “This study proves that this technique can improve the way clinicians conduct neuro scans and diagnose their patients. Neuro scans are approximately thirty percent of all MR scans; therefore MAGiC could have a tremendous impact on the MR community. GE Healthcare is committed to delivering industry-leading MR innovations that advance clinical care. We are very excited to be the first company to bring MAGiC to market for our customers and their patients. ”

MAGiC is available on GE’s Optima MR450, Optima MR450w, Discovery MR750, Discovery MR750w and Signa Pioneer MRI systems.

For more information:,

Related Content

AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...